Publicações Janeiro 2016
Dig Dis Sci. 2015 Dec 15.
Pharmacokinetics of infliximab and reduction of treatment for inflammatory bowel diseases.
Williet N, Paul S, Peyrin-Biroulet L, et al.
Read MorePharmacokinetics of infliximab and reduction of treatment for inflammatory bowel diseases.
Williet N, Paul S, Peyrin-Biroulet L, et al.
Local or national policy, patients' pre...
Publicações Fevereiro 2016
Clin Gastroenterol Hepatol. 2016 Feb 2.
The Crohn's disease-ulcerative colitis clinical appraisal.
D'Haens G, Bressler B, Danese S, et al.
Read MoreThe Crohn's disease-ulcerative colitis clinical appraisal.
D'Haens G, Bressler B, Danese S, et al.
No abstract available
Crohns Colitis. 2016 Jan 22.
Use of anti...
Publicações Março 2016
Gastroenterology. 2016 Mar 2.
Infliximab reduces endoscopic, but not clinical, recurrence of Crohn's disease following ileocolonic resection.
Regueiro M, Feagan BG, Zou B, et al.
Read MoreInfliximab reduces endoscopic, but not clinical, recurrence of Crohn's disease following ileocolonic resection.
Regueiro M, Feagan BG, Zou B, et al.
BACKGROUND & AIMS: Most ...
Publicações Abril 2016
Gastroenterology. 2016 Mar 23. [Epub ahead of print]
Efficient early drug development for ulcerative colitis.
Khanna R, Jairath V, Vande Casteele N, et al.
No abstract available.
Read MoreEfficient early drug development for ulcerative colitis.
Khanna R, Jairath V, Vande Casteele N, et al.
No abstract available.
Gastroenterology. 2016...
Publicações Maio 2016
Inflamm Bowel Dis. 2016 Apr 29.
Optimizing treatment with TNF inhibitors in inflammatory bowel disease by monitoring drug levels and antidrug antibodies.
Steenholdt C, Bendtzen K, Brynskov J, et al.
Read MoreOptimizing treatment with TNF inhibitors in inflammatory bowel disease by monitoring drug levels and antidrug antibodies.
Steenholdt C, Bendtzen K, Brynskov J, et al.
BAC...
Publicações Junho 2016
Crohns Colitis. 2016 May 25.
Histological outcomes and predictive value of faecal markers in moderately to severely active ulcerative colitis patients receiving infliximab.
Magro F, Lopes SI, Lopes J, e...
Read MoreHistological outcomes and predictive value of faecal markers in moderately to severely active ulcerative colitis patients receiving infliximab.
Magro F, Lopes SI, Lopes J, e...
Anim pariatur cliche reprehenderit, enim eiusmod high life accusamus terry richardson ad squid. 3 wolf moon officia aute, non cupidatat skateboard dolor brunch. Food truck quinoa nesciunt laborum eiusmod. Brunch 3 wolf moon tempor, sunt aliqua put a bird on it squid single-origin coffee nulla assumenda shoreditch et.
